High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan

Bone Marrow Transplantation
M H ChenC H Tzeng

Abstract

Hematopoietic SCT (HSCT) is a well-recognized therapeutic procedure to prolong life and cure patients with life-threatening hematological malignancies; however, the risk of developing secondary carcinoma may increase in long-term survivors. The objective of this study was to determine the incidence and risk factors for secondary squamous carcinoma after HSCT. Between 1984 and 2004, 170 allogeneic HSCT recipients aged >15 years, who had survived for >5 years were enrolled. Demographic data and the characteristics of secondary carcinoma were collected and analyzed for the determination of the incidence and risk of developing secondary carcinoma. Eight patients developed secondary carcinoma, including five oral squamous cell carcinomas, one esophageal, one gastric and one ovarian carcinoma, but no cutaneous carcinomas were detected at a median follow-up of 14.1 years (range, 5.1-23.3 years) after HSCT. The accrual 10-year cumulative incidence of secondary carcinoma was 2.89%. In univariate and multivariate analyses, chronic GVHD and age >40 years at the time of HSCT were both significant risk factors independently associated with the development of secondary carcinoma. Thus, the occurrence of secondary carcinoma is one of the late...Continue Reading

References

Nov 1, 1995·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Y C KoC C Tsai
Mar 27, 1997·The New England Journal of Medicine·R E CurtisJ D Boice
Nov 14, 1998·Current Opinion in Hematology·A M LittleJ A Madrigal
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G SociéM M Horowitz
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S BhatiaS J Forman
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Scott BakerLeslie L Robison
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carole Fakhry, Maura L Gillison
May 15, 2007·The New England Journal of Medicine·Gypsyamber D'SouzaMaura L Gillison
Oct 31, 2008·Blood·J Douglas RizzoH Joachim Deeg
Mar 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bipin N SavaniA John Barrett

❮ Previous
Next ❯

Citations

Jan 22, 2013·American Journal of Otolaryngology·Ameer T ShahRichard O Wein
Aug 26, 2014·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Joseph KatzJan S Moreb
May 15, 2013·Hematology/oncology and Stem Cell Therapy·Chetan MittalNalini Janakiraman
May 3, 2019·JAMA Otolaryngology-- Head & Neck Surgery·Alia MoweryDaniel Clayburgh
Nov 26, 2020·Bone Marrow Transplantation·Stella SantaronePaolo Di Bartolomeo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.